Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017030

President and CEO acquired 117,187 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Touchon Pascal President and CEO 2021-03-01 Grant or award +117,187 372,508 D
Derivatives
Touchon Pascal President and CEO 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +176,886 176,886 D
Loading xslF345X03/doc4.xml…